Search
Search Funnelback University
- Refined by:
- Date: 2022
51 -
70 of
183
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
The journey of a University idea – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/the-journey-of-a-university-idea/10 May 2022: Here are some ideas:. Performance/applications data. Prototype development, scale-up of process, develop new applications. ... parties. Example of a benefit statement. We can help primary school teachers teach children to speak a new language more -
£1.5m seed funding for Cambridge spin-out iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/university-of-cambridge-spin-out-ikva-secures-1-5m-seed-funding/2 Feb 2022: £1.5m investment via Crowdcube and Cambridge Enterprise creates new jobs and further development of the tech. -
KARPAS 707H Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-707h-human-myeloma-cell-line/9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies. -
Nyobolt: Supercharging the electric revolution – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/nyobolt-supercharging-the-electric-revolution/11 Apr 2022: A new class of battery technology. Nyobolt’s team of experts has pioneered a new class of battery technology that achieves record-breaking ultra-fast charging. -
Cambridge Enterprise 1 Cambridge Enterprise: Q&A w ith Joao ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/11/2022.11.23_AHSS-QA-Joao-Costa_Web-1.pdf23 Nov 2022: a foothold on the ground, who could go in and do preliminary consultations to grasp whether the communities could be interested or not in trying something new. -
Cambridge recognised for its leadership in knowledge exchange –…
https://www.enterprise.cam.ac.uk/news/cambridge-recognised-for-its-leadership-in-knowledge-exchange/27 Sep 2022: Early stage innovations are licensed to existing companies for development or spun out as new companies. ... Among these were three companies developing new technologies focused on reducing carbon emissions—and Carbon Re. -
KARPAS 1272 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-1272-human-myeloma-cell-line/9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge. -
Sustainability, investment and the Carbon Challenge – Cambridge…
https://www.enterprise.cam.ac.uk/video/sustainability-investment-and-the-carbon-challenge/12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge. -
Impact Insight video case study: Kalamna toolkit – Cambridge…
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-kalamna-toolkit/15 Mar 2022: Impact Insight video case study: Kalamna toolkit. The third in our new series of Impact Insight videos focuses on the licensing of the Kalamna toolkit for learning Arabic. ... Dr Khalil has spent her career researching how young Arabic learners can be -
TenU receives £4 million to boost research commercialisation –…
https://www.enterprise.cam.ac.uk/news/tenu-receives-4-million-to-boost-research-commercialisation/18 Aug 2022: with the potential to provide tens of thousands of new jobs over the next few years. -
KARPAS 241 Human Monoblastic cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-241-human-monoblastic-cell-line/9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge. -
Ceres Agri-Tech Partnership – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/ceres-a-rich-harvest-of-agri-tech-projects/11 Apr 2022: Over the past year, the team has identified and reviewed 55 new opportunities and presented 13 to the Ceres Investment Committee. -
COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/cobras-concrete-bridge-assessment-program/9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures. -
Cambridge joins $72.5m round launching mitochondrial therapies…
https://www.enterprise.cam.ac.uk/news/cambridge-joins-72-5m-round-launching-mitochondrial-therapies-pioneer-pretzel/19 Sep 2022: We are excited to pioneer a new era in the treatment of diseases related to mitochondrial dysfunction. ... The expertise we have assembled and the platform technologies we have created will allow new inroads into treating both rare genetic diseases as -
BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/boadicea-calculating-the-risk-of-breast-cancer/11 Apr 2022: New Zealand Family Cancer Services. BOADICEA being incorporated within BRRISK helps time-poor GP’s to stratify patients according to risk. ... Oncoplastic Breast Surgeon, Auckland, New Zealand. Pause. Play. If you would like more information on BOADICEA -
Brief Early Skills & Support Index (BESSI) – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/brief-early-skills-support-index-bessi/9 May 2022: Questionnaire developed at the University of Cambridge and validated for use with reception- and nursery-aged children. -
Finalists announced in 2022 Chris Abell Postdoc Business Plan…
https://www.enterprise.cam.ac.uk/news/finalists-announced-in-2022-chris-abell-postdoc-business-plan-competition/4 Oct 2022: The finalists’ pitches will be judged on a number of criteria, including each business’s competitive position, the potential for new business creation, and each team’s collective skill set. -
Case study: Futures We Want – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/consultancy-services-determining-the-futures-we-want/11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused -
Human CD59 monoclonal antibody YTH 53.1
https://www.enterprise.cam.ac.uk/reagents/human-cd59-monoclonal-antibody-yth-53-1/9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype. -
Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition…
https://www.enterprise.cam.ac.uk/news/sparxell-wins-the-2022-chris-abell-postdoc-business-plan-competition/11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.